Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod IncfiledCriticalPfizer Prod Inc
Priority to CR7881ApriorityCriticalpatent/CR7881A/en
Publication of CR7881ApublicationCriticalpatent/CR7881A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Nitrogen Condensed Heterocyclic Rings
(AREA)
Abstract
La invencion se refiere a compuestos de formula I o una sal, profarmaco o hidrato farmaceuticamente aceptable del mismo, en la que Q,A,L,R1,R2,R3 son como se han definido anteriormente. La invencion tambien se refiere a composiciones farmaceuticas que contienen los compuestos de formula 1 y a procedimientos para tratar trastornos hiperproliferativos en un mamifero por la administracion de los compuestos de formula 1.The invention relates to compounds of formula I or a pharmaceutically acceptable salt, prodrug or hydrate thereof, wherein Q, A, L, R1, R2, R3 are as defined above. The invention also relates to pharmaceutical compositions containing the compounds of formula 1 and to methods for treating hyperproliferative disorders in a mammal by the administration of the compounds of formula 1.
METHANE SULFONATES, PROPANE-1-SULPHONATES AND CYCLOPROPAN SULPHONATES REPLACED WITH [2,3,4,8-TETRAHYDROIMIDAZO- [1,5-AL-PYRIMIDIN-8-IL] -PHENYLL, PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS.